Sabra Health Care REIT delivered a productive second quarter in 2025, with significant increases in net income and FFO per share compared to the prior year. The company saw strong investment activity, improved rent coverage across its triple-net segments, and successfully transitioned managed senior housing properties to new operators. Leverage decreased, and the company updated its full-year 2025 guidance.

Sabra Health Care REIT reported strong first quarter 2025 results with significant growth in senior housing managed portfolio and improved lease coverage across portfolios. The company maintained ample liquidity and a stable credit rating while continuing to focus on strategic investments.

Sabra Health Care REIT delivered strong Q4 2024 results, driven by a 17.9% YoY increase in same-store managed senior housing Cash NOI. The company recorded net income of $46.7 million and total revenues of $182.3 million. Sabra completed acquisitions and disposals to optimize its portfolio while maintaining a strong balance sheet.

Sabra Health Care REIT reported its Q3 2024 results, showing positive performance in skilled nursing and managed senior housing. The company updated its 2024 earnings guidance, reflecting an expected year-over-year earnings growth of more than 6%. Investments for the quarter and subsequent to quarter end totaled roughly $100 million. The company's investment pipeline has seen increased activity.

Sabra Health Care REIT reported its Q2 2024 results, highlighting a net income of $0.10 per diluted common share, FFO of $0.35, normalized FFO of $0.35, AFFO of $0.36 and normalized AFFO of $0.36. The company increased its 2024 earnings guidance and experienced growth in its managed senior housing portfolio.

Sabra Health Care REIT reported first quarter 2024 results, with net income of $0.11 per diluted common share, FFO of $0.32, Normalized FFO of $0.34, AFFO of $0.35, and Normalized AFFO of $0.35. The company reiterated its 2024 earnings guidance. Sabra's portfolio continues to grow stronger, with improvements in coverage, occupancy, and NOI.

Sabra Health Care REIT announced its Q4 2023 results, with key highlights including a net income of $0.07 per diluted common share, FFO of $0.30, Normalized FFO of $0.32, and AFFO of $0.32. The company expanded its relationship with Ignite Medical Resorts through the acquisition of two skilled nursing facilities. Sabra also introduced 2024 earnings guidance and declared a quarterly cash dividend of $0.30 per share of common stock.

Sabra Health Care REIT reported a net loss of $(0.07) per diluted common share for Q3 2023. However, the company saw strong improvement in its senior housing managed portfolio and an increase in occupancy. Sabra generated $80 million from the disposition of 13 skilled nursing and two senior housing facilities, and liquidity as of September 30, 2023, was approximately $1.0 billion.

Sabra Health Care REIT reported a net income of $0.09 per diluted common share for Q2 2023. The company's portfolio is strengthening due to occupancy gains and easing labor pressures.

Sabra Health Care REIT reported a net loss of $(0.04) per diluted common share for Q1 2023. However, the company's FFO, Normalized FFO, AFFO, and Normalized AFFO were $0.32, $0.33, $0.33, and $0.34 per diluted common share, respectively. The company also made strategic acquisitions and dispositions of healthcare facilities during the quarter.

Sabra Health Care REIT reported a net loss of $(0.37) per diluted common share for Q4 2022. However, the company's FFO was $0.25, Normalized FFO was $0.37, and AFFO was $0.34. The transition of the 24-property portfolio to Ensign Group and Avamere was completed, and the company made strategic investments and dispositions during the quarter.

Sabra Health Care REIT reported a net loss for Q3 2022, but also reported positive normalized FFO and AFFO. The company is transitioning the North American portfolio to Ensign and Avamere, and is making progress on additional dispositions.

Sabra Health Care REIT reported a net income of $0.07 per diluted common share, FFO of $0.36, Normalized FFO of $0.39, AFFO of $0.36, and Normalized AFFO of $0.38 for the second quarter of 2022. The company focused on strategic portfolio adjustments, including acquisitions and dispositions, and is working towards its long-term leverage target.

Sabra Health Care REIT reported a net income of $0.18 per diluted common share for Q1 2022. The company maintained a strong Net Debt to Adjusted EBITDA ratio of 5.11x and collected 99.5% of forecasted rents since the pandemic's start. They also acquired a managed senior housing community for $26.0 million.

Sabra Health Care REIT reported a net loss of $(0.11) per diluted common share for Q4 2021. Normalized FFO was $0.39 and AFFO was $0.20. The company completed the sale of eight facilities for gross proceeds of $85.9 million and continued to maintain a strong Net Debt to Adjusted EBITDA ratio of 4.98x.

Sabra Health Care REIT announced its Q3 2021 results, with net income per diluted common share at $0.05, FFO per diluted common share at $0.27, Normalized FFO per diluted common share at $0.38, AFFO per diluted common share at $0.38 and Normalized AFFO per diluted common share at $0.38. The company reaffirmed its full-year 2021 guidance for Normalized FFO and Normalized AFFO.

Sabra Health Care REIT reported a net loss of $(0.61) per diluted common share for the second quarter of 2021. The company announced its intention to exit the Enlivant Joint Venture and provided full-year 2021 guidance. The company's Net Debt to Adjusted EBITDA ratio improved to 4.75x.

Sabra Health Care REIT reported a net income of $0.16 per diluted common share for Q1 2021. The company has collected 99.9% of forecasted rents since the pandemic's start and is seeing occupancy recovery with increased vaccine uptake and decreased infection rates.

Sabra Health Care REIT announced its Q4 2020 results, with key highlights including net income attributable to common stockholders of $0.18 per diluted common share, FFO of $0.42 per diluted common share, Normalized FFO of $0.42 per diluted common share, AFFO of $0.42 per diluted common share, and Normalized AFFO of $0.41 per diluted common share. The company also reported that EBITDARM Coverage for their Skilled Nursing/Transitional Care portfolio increased to 1.93x.

Sabra Health Care REIT announced its third quarter 2020 results, with net income attributable to common stockholders at $0.18 per diluted common share, FFO at $0.41 per diluted common share, Normalized FFO at $0.48 per diluted common share, AFFO at $0.46 per diluted common share, and Normalized AFFO at $0.46 per diluted common share. The company is no longer normalizing COVID-19 related expenses and government grant income from FFO and AFFO.

Sabra Health Care REIT reported a net income of $29.623 million for the second quarter of 2020. The company's operations were impacted by occupancy declines and increased operating expenses due to the COVID-19 pandemic. However, rent collections remained strong, and the balance sheet remained healthy with significant liquidity.

Sabra Health Care REIT reported a net income attributable to common stockholders of $35.2 million, or $0.17 per diluted common share, for the first quarter of 2020. The company acquired senior housing communities, sold skilled nursing facilities, and addressed the challenges posed by the COVID-19 pandemic, including withdrawing its 2020 earnings guidance.